PDCD1 and cutaneous melanoma: Indeed, low dose anti-CTLA4 (1 mg/kg) with full dose anti-PD1—either 3 mg/kg or 2 mg/kg has been investigated for the treatment of cutaneous melanoma in Checkmate-511 [37] or KEYNOTE-029 [38].